Exosome-based Diagnostics
Unspecified
Pre-clinicalActive
Key Facts
About EriVan Bio
EriVan Bio is a private, pre-revenue biotech company developing exosome-based research tools and therapeutic candidates. The company offers a portfolio of exosomes derived from adipose stem cells, bovine milk, and human plasma for research and biopharmaceutical manufacturing. With a leadership team combining scientific and entrepreneurial expertise, EriVan aims to advance exosome technology for targeted drug delivery, particularly in oncology, and diagnostics. Its foundation stems from award-winning academic research on miRNAs and extracellular vesicles.
View full company profileTherapeutic Areas
Other Unspecified Drugs
| Drug | Company | Phase |
|---|---|---|
| Novel Delivery Sprays & Oral Forms | Navinta | Development/NDA Filing |
| Regenerative Medicine Platform | Ibex Biosciences | Pre-clinical |
| Gene Therapy Programs | Ibex Biosciences | Pre-clinical |